Skip to main content
. 2019 May 13;5(2):e12603. doi: 10.2196/12603

Table 2.

Characteristics of Hispanic/Latino and non-Hispanic colorectal cancer survivors who received a pneumococcal vaccination.

Characteristics Received PNMa vaccine, n (%) Did not receive PNM vaccine, n (%)

Hispanic (n=727, 4.5%) Non-Hispanic (n=15525, 95.53%) P value Hispanic (n=782, 4.8%) Non-Hispanic (n=15,467; 95.19%) P value
Age at diagnosis (years)

66-69 158 (21.7) 2465 (15.88) <.001 157 (20.1) 2587 (16.73) <.001
70-74 210 (28.9) 4094 (26.37) <.001 226 (28.9) 3677 (23.77) <.001
75-79 195 (26.8) 4027 (25.94) <.001 202 (25.8) 3859 (24.95) <.001
80-84 106 (14.6) 3069 (19.77) <.001 126 (16.1) 3106 (20.08) <.001
85+ 58 (8) 1870 (12.05) <.001 71 (9) 2238 (14.47) <.001
Gender
Male 360 (49.5) 6541 (42.13) <.001 394 (50.4) 6698 (43.31) <.001
Female 367 (50.5) 8984 (57.87) <.001 388 (49.6) 8769 (56.69) <.001
Urban status
Urban 678 (93.3) 13879 (89.40) <.001 735 (94) 13241 (85.61) <0001
Rural 49 (7) 1646 (10.60) <.001 47 (6) 2226 (14.39) <.001
Federal Poverty Level (%)
0 to <5 107 (14.7) 4956 (31.92) <.001 125 (16.0) 4276 (27.65) <.001
5 to <10 146 (20.1) 4471 (28.80) <.001 159 (20.3) 4385 (28.35) <.001
10 to <20 251 (34.5) 4002 (25.78) <.001 269 (34.4) 4273 (27.63) <.001
20 to 100 223 (30.7) 2096 (13.50) <.001 229 (29.3) 2533 (16.38) <.001
Charlson Comorbidity Index
0 400 (55.0) 9947 (64.07) <.001 510 (65.2) 10950 (70.8) .006
1 200 (27.5) 3811 (24.55) <.001 181 (23.2) 3147 (20.35) .006
2 81 (11) 1261 (8.12) <.001 65 (8) 965 (6.2) .006
3 or more 46 (6) 506 (3.3) <.001 26 (3) 405 (2.6) .006
Marital status
Divorced 46 (6) 812 (5.2) .03 54 (7) 888 (5.7) .04
Married 403 (55.4) 8606 (55.43) .03 403 (51.5) 8061 (52.12) .04
Other 215 (29.6) 5095 (32.82) .03 253 (32.4) 5424 (35.07) .04
Single 63 (9) 1012 (6.52) .03 72 (9) 1094 (7.07) .04
Tumor stage at diagnosis
Localized 416 (57.2) 9088 (58.54) .92 406 (51.9) 8779 (56.76) .03
Regional 279 (38.4) 5781 (37.24) .92 335 (42.8) 5902 (38.16) .03
Distant 19 (3) 388 (2.5) .92 19 (2) 444 (2.9) .03
Unstaged 13 (2) 268 (1.7) .92 22 (3) 342 (2.2) .03
Surveillance, Epidemiology, and End Results registry region
San Francisco 41 (6) 516 (3.3) <.001 35 (4) 527 (3.4) <.001
Connecticut 29 (4) 1151 (7.41) <.001 24 (3) 1057 (6.83) <.001
San Jose 39 (5) 364 (2.3) <.001 31 (4) 287 (1.9) <.001
Los Angeles 104 (14.3) 975 (6.3) <.001 125 (15.98) 916 (5.9) <.001
Greater California 230 (31.6) 2360 (15.20) <.001 278 (35.6) 2256 (14.59) <.001
New Jersey 113 (15.5) 2800 (18.04) <.001 126 (16.1) 2581 (16.69) <.001
New Mexico 104 (14.3) 288 (1.9) <.001 89 (11) 263 (1.7) <.001
Other 67 (9) 7071 (45.55) <.001 74 (9) 7580 (49.01) <.001

aPNM: pneumococcal.